It could be that significant enrichment of the P53 signaling pathway, the WNT signaling pathway, basal cell carcinoma, and other cancer-related pathways in m6Acluster 1 lead to the poor survival of patients in m6Acluster 1. The gene discussed is TP53; the disease is cancer.